0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Melanoma Cancer Diagnostics Market Insights, Forecast to 2028
Published Date: April 2022
|
Report Code: QYRE-Auto-31D4005
Home | Market Reports | Health | Health Conditions | Cancer
Global Melanoma Cancer Diagnostics Market Insights Forecast to 2028

Global Melanoma Cancer Diagnostics Market Insights, Forecast to 2028

Code: QYRE-Auto-31D4005
Report
April 2022
93 Pages
QYResearch
Region: Global, North America, UAE, Saudi Arabia, Turkey, Southeast Asia, Europe, Germany, Canada, France, Russia, South Korea, Italy,
Description
Table of Content
Tables & Figures
Melanoma is a type of skin cancer developing from pigment-containing cells known as melanocytes. Melanoma cancer diagnostics is to diagnose melanoma with biopsy. During a biopsy, all or the part of mole or growth over the skin is removed to test and analyze the sample. Common biopsy procedures used to diagnose melanoma are punch biopsy, incisional biopsy, and excisional biopsy.
Market Analysis and Insights: Global Melanoma Cancer Diagnostics Market

The global Melanoma Cancer Diagnostics market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

Fully considering the economic change by this health crisis, Fluorescent In Situ Hybridization (FISH) Tests accounting for % of the Melanoma Cancer Diagnostics global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Melanoma Cancer Diagnostics market size is valued at US$ million in 2021, while the North America and Europe Melanoma Cancer Diagnostics are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Melanoma Cancer Diagnostics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Melanoma Cancer Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Melanoma Cancer Diagnostics market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Melanoma Cancer Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Melanoma Cancer Diagnostics market.
Global Melanoma Cancer Diagnostics Scope and Market Size
Melanoma Cancer Diagnostics market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Melanoma Cancer Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Fluorescent In Situ Hybridization (FISH) Tests
Comparative Genomic Hybridization (CGH) Tests
Immunohistochemical (IHC) Tests

Segment by Application

Hospitals
Clinics
Cancer Research Centres
Others

BY COMPANY

AB Sciences
Incyte
Merck
Novartis
Pierre Fabre
Amgen
AstraZeneca
Bristol-Myers Squibb
Daiichi Sankyo

BY REGION

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Melanoma Cancer Diagnostics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Fluorescent In Situ Hybridization (FISH) Tests
1.2.3 Comparative Genomic Hybridization (CGH) Tests
1.2.4 Immunohistochemical (IHC) Tests
1.3 Market by Application
1.3.1 Global Melanoma Cancer Diagnostics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Cancer Research Centres
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Melanoma Cancer Diagnostics Market Perspective (2017-2028)
2.2 Melanoma Cancer Diagnostics Growth Trends by Region
2.2.1 Melanoma Cancer Diagnostics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Melanoma Cancer Diagnostics Historic Market Size by Region (2017-2022)
2.2.3 Melanoma Cancer Diagnostics Forecasted Market Size by Region (2023-2028)
2.3 Melanoma Cancer Diagnostics Market Dynamics
2.3.1 Melanoma Cancer Diagnostics Industry Trends
2.3.2 Melanoma Cancer Diagnostics Market Drivers
2.3.3 Melanoma Cancer Diagnostics Market Challenges
2.3.4 Melanoma Cancer Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Melanoma Cancer Diagnostics Players by Revenue
3.1.1 Global Top Melanoma Cancer Diagnostics Players by Revenue (2017-2022)
3.1.2 Global Melanoma Cancer Diagnostics Revenue Market Share by Players (2017-2022)
3.2 Global Melanoma Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Melanoma Cancer Diagnostics Revenue
3.4 Global Melanoma Cancer Diagnostics Market Concentration Ratio
3.4.1 Global Melanoma Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Melanoma Cancer Diagnostics Revenue in 2021
3.5 Melanoma Cancer Diagnostics Key Players Head office and Area Served
3.6 Key Players Melanoma Cancer Diagnostics Product Solution and Service
3.7 Date of Enter into Melanoma Cancer Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Melanoma Cancer Diagnostics Breakdown Data by Type
4.1 Global Melanoma Cancer Diagnostics Historic Market Size by Type (2017-2022)
4.2 Global Melanoma Cancer Diagnostics Forecasted Market Size by Type (2023-2028)
5 Melanoma Cancer Diagnostics Breakdown Data by Application
5.1 Global Melanoma Cancer Diagnostics Historic Market Size by Application (2017-2022)
5.2 Global Melanoma Cancer Diagnostics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Melanoma Cancer Diagnostics Market Size (2017-2028)
6.2 North America Melanoma Cancer Diagnostics Market Size by Type
6.2.1 North America Melanoma Cancer Diagnostics Market Size by Type (2017-2022)
6.2.2 North America Melanoma Cancer Diagnostics Market Size by Type (2023-2028)
6.2.3 North America Melanoma Cancer Diagnostics Market Share by Type (2017-2028)
6.3 North America Melanoma Cancer Diagnostics Market Size by Application
6.3.1 North America Melanoma Cancer Diagnostics Market Size by Application (2017-2022)
6.3.2 North America Melanoma Cancer Diagnostics Market Size by Application (2023-2028)
6.3.3 North America Melanoma Cancer Diagnostics Market Share by Application (2017-2028)
6.4 North America Melanoma Cancer Diagnostics Market Size by Country
6.4.1 North America Melanoma Cancer Diagnostics Market Size by Country (2017-2022)
6.4.2 North America Melanoma Cancer Diagnostics Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Melanoma Cancer Diagnostics Market Size (2017-2028)
7.2 Europe Melanoma Cancer Diagnostics Market Size by Type
7.2.1 Europe Melanoma Cancer Diagnostics Market Size by Type (2017-2022)
7.2.2 Europe Melanoma Cancer Diagnostics Market Size by Type (2023-2028)
7.2.3 Europe Melanoma Cancer Diagnostics Market Share by Type (2017-2028)
7.3 Europe Melanoma Cancer Diagnostics Market Size by Application
7.3.1 Europe Melanoma Cancer Diagnostics Market Size by Application (2017-2022)
7.3.2 Europe Melanoma Cancer Diagnostics Market Size by Application (2023-2028)
7.3.3 Europe Melanoma Cancer Diagnostics Market Share by Application (2017-2028)
7.4 Europe Melanoma Cancer Diagnostics Market Size by Country
7.4.1 Europe Melanoma Cancer Diagnostics Market Size by Country (2017-2022)
7.4.2 Europe Melanoma Cancer Diagnostics Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Melanoma Cancer Diagnostics Market Size (2017-2028)
8.2 Asia-Pacific Melanoma Cancer Diagnostics Market Size by Type
8.2.1 Asia-Pacific Melanoma Cancer Diagnostics Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Melanoma Cancer Diagnostics Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Melanoma Cancer Diagnostics Market Share by Type (2017-2028)
8.3 Asia-Pacific Melanoma Cancer Diagnostics Market Size by Application
8.3.1 Asia-Pacific Melanoma Cancer Diagnostics Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Melanoma Cancer Diagnostics Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Melanoma Cancer Diagnostics Market Share by Application (2017-2028)
8.4 Asia-Pacific Melanoma Cancer Diagnostics Market Size by Region
8.4.1 Asia-Pacific Melanoma Cancer Diagnostics Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Melanoma Cancer Diagnostics Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Melanoma Cancer Diagnostics Market Size (2017-2028)
9.2 Latin America Melanoma Cancer Diagnostics Market Size by Type
9.2.1 Latin America Melanoma Cancer Diagnostics Market Size by Type (2017-2022)
9.2.2 Latin America Melanoma Cancer Diagnostics Market Size by Type (2023-2028)
9.2.3 Latin America Melanoma Cancer Diagnostics Market Share by Type (2017-2028)
9.3 Latin America Melanoma Cancer Diagnostics Market Size by Application
9.3.1 Latin America Melanoma Cancer Diagnostics Market Size by Application (2017-2022)
9.3.2 Latin America Melanoma Cancer Diagnostics Market Size by Application (2023-2028)
9.3.3 Latin America Melanoma Cancer Diagnostics Market Share by Application (2017-2028)
9.4 Latin America Melanoma Cancer Diagnostics Market Size by Country
9.4.1 Latin America Melanoma Cancer Diagnostics Market Size by Country (2017-2022)
9.4.2 Latin America Melanoma Cancer Diagnostics Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Melanoma Cancer Diagnostics Market Size (2017-2028)
10.2 Middle East & Africa Melanoma Cancer Diagnostics Market Size by Type
10.2.1 Middle East & Africa Melanoma Cancer Diagnostics Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Melanoma Cancer Diagnostics Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Melanoma Cancer Diagnostics Market Share by Type (2017-2028)
10.3 Middle East & Africa Melanoma Cancer Diagnostics Market Size by Application
10.3.1 Middle East & Africa Melanoma Cancer Diagnostics Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Melanoma Cancer Diagnostics Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Melanoma Cancer Diagnostics Market Share by Application (2017-2028)
10.4 Middle East & Africa Melanoma Cancer Diagnostics Market Size by Country
10.4.1 Middle East & Africa Melanoma Cancer Diagnostics Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Melanoma Cancer Diagnostics Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AB Sciences
11.1.1 AB Sciences Company Details
11.1.2 AB Sciences Business Overview
11.1.3 AB Sciences Melanoma Cancer Diagnostics Introduction
11.1.4 AB Sciences Revenue in Melanoma Cancer Diagnostics Business (2017-2022)
11.1.5 AB Sciences Recent Developments
11.2 Incyte
11.2.1 Incyte Company Details
11.2.2 Incyte Business Overview
11.2.3 Incyte Melanoma Cancer Diagnostics Introduction
11.2.4 Incyte Revenue in Melanoma Cancer Diagnostics Business (2017-2022)
11.2.5 Incyte Recent Developments
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Melanoma Cancer Diagnostics Introduction
11.3.4 Merck Revenue in Melanoma Cancer Diagnostics Business (2017-2022)
11.3.5 Merck Recent Developments
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Melanoma Cancer Diagnostics Introduction
11.4.4 Novartis Revenue in Melanoma Cancer Diagnostics Business (2017-2022)
11.4.5 Novartis Recent Developments
11.5 Pierre Fabre
11.5.1 Pierre Fabre Company Details
11.5.2 Pierre Fabre Business Overview
11.5.3 Pierre Fabre Melanoma Cancer Diagnostics Introduction
11.5.4 Pierre Fabre Revenue in Melanoma Cancer Diagnostics Business (2017-2022)
11.5.5 Pierre Fabre Recent Developments
11.6 Amgen
11.6.1 Amgen Company Details
11.6.2 Amgen Business Overview
11.6.3 Amgen Melanoma Cancer Diagnostics Introduction
11.6.4 Amgen Revenue in Melanoma Cancer Diagnostics Business (2017-2022)
11.6.5 Amgen Recent Developments
11.7 AstraZeneca
11.7.1 AstraZeneca Company Details
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Melanoma Cancer Diagnostics Introduction
11.7.4 AstraZeneca Revenue in Melanoma Cancer Diagnostics Business (2017-2022)
11.7.5 AstraZeneca Recent Developments
11.8 Bristol-Myers Squibb
11.8.1 Bristol-Myers Squibb Company Details
11.8.2 Bristol-Myers Squibb Business Overview
11.8.3 Bristol-Myers Squibb Melanoma Cancer Diagnostics Introduction
11.8.4 Bristol-Myers Squibb Revenue in Melanoma Cancer Diagnostics Business (2017-2022)
11.8.5 Bristol-Myers Squibb Recent Developments
11.9 Daiichi Sankyo
11.9.1 Daiichi Sankyo Company Details
11.9.2 Daiichi Sankyo Business Overview
11.9.3 Daiichi Sankyo Melanoma Cancer Diagnostics Introduction
11.9.4 Daiichi Sankyo Revenue in Melanoma Cancer Diagnostics Business (2017-2022)
11.9.5 Daiichi Sankyo Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
    Table 1. Global Melanoma Cancer Diagnostics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Fluorescent In Situ Hybridization (FISH) Tests
    Table 3. Key Players of Comparative Genomic Hybridization (CGH) Tests
    Table 4. Key Players of Immunohistochemical (IHC) Tests
    Table 5. Global Melanoma Cancer Diagnostics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 6. Global Melanoma Cancer Diagnostics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Melanoma Cancer Diagnostics Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Melanoma Cancer Diagnostics Market Share by Region (2017-2022)
    Table 9. Global Melanoma Cancer Diagnostics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Melanoma Cancer Diagnostics Market Share by Region (2023-2028)
    Table 11. Melanoma Cancer Diagnostics Market Trends
    Table 12. Melanoma Cancer Diagnostics Market Drivers
    Table 13. Melanoma Cancer Diagnostics Market Challenges
    Table 14. Melanoma Cancer Diagnostics Market Restraints
    Table 15. Global Melanoma Cancer Diagnostics Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Melanoma Cancer Diagnostics Revenue Share by Players (2017-2022)
    Table 17. Global Top Melanoma Cancer Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Melanoma Cancer Diagnostics as of 2021)
    Table 18. Ranking of Global Top Melanoma Cancer Diagnostics Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Melanoma Cancer Diagnostics Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Melanoma Cancer Diagnostics Product Solution and Service
    Table 22. Date of Enter into Melanoma Cancer Diagnostics Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Melanoma Cancer Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Melanoma Cancer Diagnostics Revenue Market Share by Type (2017-2022)
    Table 26. Global Melanoma Cancer Diagnostics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Melanoma Cancer Diagnostics Revenue Market Share by Type (2023-2028)
    Table 28. Global Melanoma Cancer Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Melanoma Cancer Diagnostics Revenue Share by Application (2017-2022)
    Table 30. Global Melanoma Cancer Diagnostics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Melanoma Cancer Diagnostics Revenue Share by Application (2023-2028)
    Table 32. North America Melanoma Cancer Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 33. North America Melanoma Cancer Diagnostics Market Size by Type (2023-2028) & (US$ Million)
    Table 34. North America Melanoma Cancer Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 35. North America Melanoma Cancer Diagnostics Market Size by Application (2023-2028) & (US$ Million)
    Table 36. North America Melanoma Cancer Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 37. North America Melanoma Cancer Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Europe Melanoma Cancer Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 39. Europe Melanoma Cancer Diagnostics Market Size by Type (2023-2028) & (US$ Million)
    Table 40. Europe Melanoma Cancer Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 41. Europe Melanoma Cancer Diagnostics Market Size by Application (2023-2028) & (US$ Million)
    Table 42. Europe Melanoma Cancer Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Europe Melanoma Cancer Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Asia Pacific Melanoma Cancer Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 45. Asia Pacific Melanoma Cancer Diagnostics Market Size by Type (2023-2028) & (US$ Million)
    Table 46. Asia Pacific Melanoma Cancer Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 47. Asia Pacific Melanoma Cancer Diagnostics Market Size by Application (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Melanoma Cancer Diagnostics Market Size by Region (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Melanoma Cancer Diagnostics Market Size by Region (2023-2028) & (US$ Million)
    Table 50. Latin America Melanoma Cancer Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 51. Latin America Melanoma Cancer Diagnostics Market Size by Type (2023-2028) & (US$ Million)
    Table 52. Latin America Melanoma Cancer Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 53. Latin America Melanoma Cancer Diagnostics Market Size by Application (2023-2028) & (US$ Million)
    Table 54. Latin America Melanoma Cancer Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 55. Latin America Melanoma Cancer Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 56. Middle East and Africa Melanoma Cancer Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 57. Middle East and Africa Melanoma Cancer Diagnostics Market Size by Type (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa Melanoma Cancer Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa Melanoma Cancer Diagnostics Market Size by Application (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Melanoma Cancer Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Melanoma Cancer Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 62. AB Sciences Company Details
    Table 63. AB Sciences Business Overview
    Table 64. AB Sciences Melanoma Cancer Diagnostics Product
    Table 65. AB Sciences Revenue in Melanoma Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 66. AB Sciences Recent Developments
    Table 67. Incyte Company Details
    Table 68. Incyte Business Overview
    Table 69. Incyte Melanoma Cancer Diagnostics Product
    Table 70. Incyte Revenue in Melanoma Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 71. Incyte Recent Developments
    Table 72. Merck Company Details
    Table 73. Merck Business Overview
    Table 74. Merck Melanoma Cancer Diagnostics Product
    Table 75. Merck Revenue in Melanoma Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 76. Merck Recent Developments
    Table 77. Novartis Company Details
    Table 78. Novartis Business Overview
    Table 79. Novartis Melanoma Cancer Diagnostics Product
    Table 80. Novartis Revenue in Melanoma Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 81. Novartis Recent Developments
    Table 82. Pierre Fabre Company Details
    Table 83. Pierre Fabre Business Overview
    Table 84. Pierre Fabre Melanoma Cancer Diagnostics Product
    Table 85. Pierre Fabre Revenue in Melanoma Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 86. Pierre Fabre Recent Developments
    Table 87. Amgen Company Details
    Table 88. Amgen Business Overview
    Table 89. Amgen Melanoma Cancer Diagnostics Product
    Table 90. Amgen Revenue in Melanoma Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 91. Amgen Recent Developments
    Table 92. AstraZeneca Company Details
    Table 93. AstraZeneca Business Overview
    Table 94. AstraZeneca Melanoma Cancer Diagnostics Product
    Table 95. AstraZeneca Revenue in Melanoma Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 96. AstraZeneca Recent Developments
    Table 97. Bristol-Myers Squibb Company Details
    Table 98. Bristol-Myers Squibb Business Overview
    Table 99. Bristol-Myers Squibb Melanoma Cancer Diagnostics Product
    Table 100. Bristol-Myers Squibb Revenue in Melanoma Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 101. Bristol-Myers Squibb Recent Developments
    Table 102. Daiichi Sankyo Company Details
    Table 103. Daiichi Sankyo Business Overview
    Table 104. Daiichi Sankyo Melanoma Cancer Diagnostics Product
    Table 105. Daiichi Sankyo Revenue in Melanoma Cancer Diagnostics Business (2017-2022) & (US$ Million)
    Table 106. Daiichi Sankyo Recent Developments
    Table 107. Research Programs/Design for This Report
    Table 108. Key Data Information from Secondary Sources
    Table 109. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Melanoma Cancer Diagnostics Market Share by Type: 2021 VS 2028
    Figure 2. Fluorescent In Situ Hybridization (FISH) Tests Features
    Figure 3. Comparative Genomic Hybridization (CGH) Tests Features
    Figure 4. Immunohistochemical (IHC) Tests Features
    Figure 5. Global Melanoma Cancer Diagnostics Market Share by Application: 2021 VS 2028
    Figure 6. Hospitals Case Studies
    Figure 7. Clinics Case Studies
    Figure 8. Cancer Research Centres Case Studies
    Figure 9. Others Case Studies
    Figure 10. Melanoma Cancer Diagnostics Report Years Considered
    Figure 11. Global Melanoma Cancer Diagnostics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Melanoma Cancer Diagnostics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Melanoma Cancer Diagnostics Market Share by Region: 2021 VS 2028
    Figure 14. Global Melanoma Cancer Diagnostics Market Share by Players in 2021
    Figure 15. Global Top Melanoma Cancer Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Melanoma Cancer Diagnostics as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Melanoma Cancer Diagnostics Revenue in 2021
    Figure 17. North America Melanoma Cancer Diagnostics Market Size YoY (2017-2028) & (US$ Million)
    Figure 18. North America Melanoma Cancer Diagnostics Market Size Market Share by Type (2017-2028)
    Figure 19. North America Melanoma Cancer Diagnostics Market Size Market Share by Application (2017-2028)
    Figure 20. North America Melanoma Cancer Diagnostics Market Size Share by Country (2017-2028)
    Figure 21. United States Melanoma Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Canada Melanoma Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Melanoma Cancer Diagnostics Market Size YoY (2017-2028) & (US$ Million)
    Figure 24. Europe Melanoma Cancer Diagnostics Market Size Market Share by Type (2017-2028)
    Figure 25. Europe Melanoma Cancer Diagnostics Market Size Market Share by Application (2017-2028)
    Figure 26. Europe Melanoma Cancer Diagnostics Market Size Share by Country (2017-2028)
    Figure 27. Germany Melanoma Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. France Melanoma Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. U.K. Melanoma Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Italy Melanoma Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Russia Melanoma Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Nordic Countries Melanoma Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific Melanoma Cancer Diagnostics Market Size YoY (2017-2028) & (US$ Million)
    Figure 34. Asia Pacific Melanoma Cancer Diagnostics Market Size Market Share by Type (2017-2028)
    Figure 35. Asia Pacific Melanoma Cancer Diagnostics Market Size Market Share by Application (2017-2028)
    Figure 36. Asia Pacific Melanoma Cancer Diagnostics Market Size Share by Region (2017-2028)
    Figure 37. China Melanoma Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Japan Melanoma Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. South Korea Melanoma Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Southeast Asia Melanoma Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. India Melanoma Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Australia Melanoma Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 43. Latin America Melanoma Cancer Diagnostics Market Size YoY (2017-2028) & (US$ Million)
    Figure 44. Latin America Melanoma Cancer Diagnostics Market Size Market Share by Type (2017-2028)
    Figure 45. Latin America Melanoma Cancer Diagnostics Market Size Market Share by Application (2017-2028)
    Figure 46. Latin America Melanoma Cancer Diagnostics Market Size Share by Country (2017-2028)
    Figure 47. Mexico Melanoma Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Brazil Melanoma Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Middle East & Africa Melanoma Cancer Diagnostics Market Size YoY (2017-2028) & (US$ Million)
    Figure 50. Middle East and Africa Melanoma Cancer Diagnostics Market Size Market Share by Type (2017-2028)
    Figure 51. Middle East and Africa Melanoma Cancer Diagnostics Market Size Market Share by Application (2017-2028)
    Figure 52. Middle East and Africa Melanoma Cancer Diagnostics Market Size Share by Country (2017-2028)
    Figure 53. Turkey Melanoma Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Saudi Arabia Melanoma Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. UAE Melanoma Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. AB Sciences Revenue Growth Rate in Melanoma Cancer Diagnostics Business (2017-2022)
    Figure 57. Incyte Revenue Growth Rate in Melanoma Cancer Diagnostics Business (2017-2022)
    Figure 58. Merck Revenue Growth Rate in Melanoma Cancer Diagnostics Business (2017-2022)
    Figure 59. Novartis Revenue Growth Rate in Melanoma Cancer Diagnostics Business (2017-2022)
    Figure 60. Pierre Fabre Revenue Growth Rate in Melanoma Cancer Diagnostics Business (2017-2022)
    Figure 61. Amgen Revenue Growth Rate in Melanoma Cancer Diagnostics Business (2017-2022)
    Figure 62. AstraZeneca Revenue Growth Rate in Melanoma Cancer Diagnostics Business (2017-2022)
    Figure 63. Bristol-Myers Squibb Revenue Growth Rate in Melanoma Cancer Diagnostics Business (2017-2022)
    Figure 64. Daiichi Sankyo Revenue Growth Rate in Melanoma Cancer Diagnostics Business (2017-2022)
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4900
This license allows only one user(purchaser of the report) to access the PDF.

Electronic (PDF)
$7350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$9800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Novocure
SIMILAR REPORTS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global and United States Blood Cancer Therapeutics Market Report Forecast 2022 2028
Global and United States Blood Cancer Therapeutics Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-24U5687
Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Global and United States Ovarian Cancer Diagnostics Technologies Market Report Forecast 2022 2028
Global and United States Ovarian Cancer Diagnostics Technologies Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-23K5690
Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Global and United States Cancer Biotherapy Market Report Forecast 2022 2028
Global and United States Cancer Biotherapy Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-18N5929
Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Global and United States Emerging Cancer Diagnostics Market Report Forecast 2022 2028
Global and United States Emerging Cancer Diagnostics Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-12C6010
Tue Jun 07 00:00:00 UTC 2022

Add to Cart